The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Pancreas Devices Systems Market Research Report 2024
Synopsis
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The global Artificial Pancreas Devices Systems market was valued at US$ 89 million in 2023 and is anticipated to reach US$ 199.8 million by 2030, witnessing a CAGR of 12.1% during the forecast period 2024-2030.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report aims to provide a comprehensive presentation of the global market for Artificial Pancreas Devices Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pancreas Devices Systems.
Report Scope
The Artificial Pancreas Devices Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Pancreas Devices Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Pancreas Devices Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Pancreas Devices Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The global Artificial Pancreas Devices Systems market was valued at US$ 89 million in 2023 and is anticipated to reach US$ 199.8 million by 2030, witnessing a CAGR of 12.1% during the forecast period 2024-2030.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report aims to provide a comprehensive presentation of the global market for Artificial Pancreas Devices Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pancreas Devices Systems.
Report Scope
The Artificial Pancreas Devices Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Pancreas Devices Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Pancreas Devices Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Pancreas Devices Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Artificial Pancreas Devices Systems Market Overview
1.1 Product Overview and Scope of Artificial Pancreas Devices Systems
1.2 Artificial Pancreas Devices Systems Segment by Type
1.2.1 Global Artificial Pancreas Devices Systems Market Value Comparison by Type (2024-2030)
1.2.2 Threshold Suspended Device Systems
1.2.3 Hybrid Closed-loop APDS
1.2.4 Other Systems
1.3 Artificial Pancreas Devices Systems Segment by Application
1.3.1 Global Artificial Pancreas Devices Systems Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Artificial Pancreas Devices Systems Market Size Estimates and Forecasts
1.4.1 Global Artificial Pancreas Devices Systems Revenue 2019-2030
1.4.2 Global Artificial Pancreas Devices Systems Sales 2019-2030
1.4.3 Global Artificial Pancreas Devices Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artificial Pancreas Devices Systems Market Competition by Manufacturers
2.1 Global Artificial Pancreas Devices Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artificial Pancreas Devices Systems Average Price by Manufacturers (2019-2024)
2.4 Global Artificial Pancreas Devices Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Pancreas Devices Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Pancreas Devices Systems, Product Type & Application
2.7 Artificial Pancreas Devices Systems Market Competitive Situation and Trends
2.7.1 Artificial Pancreas Devices Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artificial Pancreas Devices Systems Players Market Share by Revenue
2.7.3 Global Artificial Pancreas Devices Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Pancreas Devices Systems Retrospective Market Scenario by Region
3.1 Global Artificial Pancreas Devices Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artificial Pancreas Devices Systems Global Artificial Pancreas Devices Systems Sales by Region: 2019-2030
3.2.1 Global Artificial Pancreas Devices Systems Sales by Region: 2019-2024
3.2.2 Global Artificial Pancreas Devices Systems Sales by Region: 2025-2030
3.3 Global Artificial Pancreas Devices Systems Global Artificial Pancreas Devices Systems Revenue by Region: 2019-2030
3.3.1 Global Artificial Pancreas Devices Systems Revenue by Region: 2019-2024
3.3.2 Global Artificial Pancreas Devices Systems Revenue by Region: 2025-2030
3.4 North America Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.4.1 North America Artificial Pancreas Devices Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artificial Pancreas Devices Systems Sales by Country (2019-2030)
3.4.3 North America Artificial Pancreas Devices Systems Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.5.1 Europe Artificial Pancreas Devices Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artificial Pancreas Devices Systems Sales by Country (2019-2030)
3.5.3 Europe Artificial Pancreas Devices Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Artificial Pancreas Devices Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artificial Pancreas Devices Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Artificial Pancreas Devices Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.7.1 Latin America Artificial Pancreas Devices Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artificial Pancreas Devices Systems Sales by Country (2019-2030)
3.7.3 Latin America Artificial Pancreas Devices Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Pancreas Devices Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Pancreas Devices Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artificial Pancreas Devices Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Artificial Pancreas Devices Systems Sales by Type (2019-2030)
4.1.1 Global Artificial Pancreas Devices Systems Sales by Type (2019-2024)
4.1.2 Global Artificial Pancreas Devices Systems Sales by Type (2025-2030)
4.1.3 Global Artificial Pancreas Devices Systems Sales Market Share by Type (2019-2030)
4.2 Global Artificial Pancreas Devices Systems Revenue by Type (2019-2030)
4.2.1 Global Artificial Pancreas Devices Systems Revenue by Type (2019-2024)
4.2.2 Global Artificial Pancreas Devices Systems Revenue by Type (2025-2030)
4.2.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Type (2019-2030)
4.3 Global Artificial Pancreas Devices Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artificial Pancreas Devices Systems Sales by Application (2019-2030)
5.1.1 Global Artificial Pancreas Devices Systems Sales by Application (2019-2024)
5.1.2 Global Artificial Pancreas Devices Systems Sales by Application (2025-2030)
5.1.3 Global Artificial Pancreas Devices Systems Sales Market Share by Application (2019-2030)
5.2 Global Artificial Pancreas Devices Systems Revenue by Application (2019-2030)
5.2.1 Global Artificial Pancreas Devices Systems Revenue by Application (2019-2024)
5.2.2 Global Artificial Pancreas Devices Systems Revenue by Application (2025-2030)
5.2.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Application (2019-2030)
5.3 Global Artificial Pancreas Devices Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Bigfoot Biomedical
6.2.1 Bigfoot Biomedical Corporation Information
6.2.2 Bigfoot Biomedical Description and Business Overview
6.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
6.2.5 Bigfoot Biomedical Recent Developments/Updates
6.3 Beta Bionics
6.3.1 Beta Bionics Corporation Information
6.3.2 Beta Bionics Description and Business Overview
6.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
6.3.5 Beta Bionics Recent Developments/Updates
6.4 Admetsys
6.4.1 Admetsys Corporation Information
6.4.2 Admetsys Description and Business Overview
6.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
6.4.5 Admetsys Recent Developments/Updates
6.5 Insulet
6.5.1 Insulet Corporation Information
6.5.2 Insulet Description and Business Overview
6.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
6.5.5 Insulet Recent Developments/Updates
6.6 Tandem Diabetes Care
6.6.1 Tandem Diabetes Care Corporation Information
6.6.2 Tandem Diabetes Care Description and Business Overview
6.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
6.6.5 Tandem Diabetes Care Recent Developments/Updates
6.7 Defymed
6.6.1 Defymed Corporation Information
6.6.2 Defymed Description and Business Overview
6.6.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
6.7.5 Defymed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Pancreas Devices Systems Industry Chain Analysis
7.2 Artificial Pancreas Devices Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Pancreas Devices Systems Production Mode & Process
7.4 Artificial Pancreas Devices Systems Sales and Marketing
7.4.1 Artificial Pancreas Devices Systems Sales Channels
7.4.2 Artificial Pancreas Devices Systems Distributors
7.5 Artificial Pancreas Devices Systems Customers
8 Artificial Pancreas Devices Systems Market Dynamics
8.1 Artificial Pancreas Devices Systems Industry Trends
8.2 Artificial Pancreas Devices Systems Market Drivers
8.3 Artificial Pancreas Devices Systems Market Challenges
8.4 Artificial Pancreas Devices Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
